Zobrazeno 1 - 10
of 362
pro vyhledávání: '"Arthur L. Barry"'
Autor:
Barry, A.L.1
Publikováno v:
Drugs. Apr2001, Vol. 61 Issue 6, p830-831. 2p.
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 21:407-410
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:2662-2665
Quinupristin-dalfopristin (Q-D) and eight other antimicrobial agents were tested alone and in combination with Q-D in time-kill studies against 10 strains of macrolide-lincosamide-streptogramin B-resistant Staphylococcus aureus . Although Q-D is norm
Publikováno v:
European Journal of Clinical Microbiology and Infections Diseases. 20:0494-0497
A ketolide (telithromycin), an azalide (azithromycin) and a macrolide (erythromycin) were tested against 2,733 isolates of gram-positive cocci gathered from 11 different medical centers. Telithromycin was active against erythromycin-resistant staphyl
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:1923-1927
In vitro susceptibility tests were performed to document the inhibitory activities of three nonfluorinated quinolone (NFQ) compounds (PGE 9262932, PGE 9509924, and PGE 4175997) compared to those of ciprofloxacin, levofloxacin, and trovafloxacin again
Publikováno v:
Journal of Antimicrobial Chemotherapy. 43:137-140
One hundred percent of 1097 Escherichia coli and 97.5% of 157 Enterococcus faecalis isolates from outpatient urine specimens at ten North American medical centres were susceptible to fosfomycin tromethamine. The Etest MICs correlated well with those
Publikováno v:
Antimicrobial Agents and Chemotherapy. 42:1274-1277
Clinafloxacin was more active than ciprofloxacin against 4,213 aerobic and facultative anaerobic bacterial isolates from 10 medical centers, as tested by broth microdilution and disk diffusion methods. The percentage of 201 anaerobes susceptible to c
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 26:23-27
Broth microdilution and disk diffusion methods were used to test ciprofloxacin, clinafloxacin, fleroxacin, grepafloxacin, ofloxacin, PD131628, sparfloxacin, and trovafloxacin against Streptococcus pneumoniae isolates. With each fluoroquinolone tested
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 15:678-682
The activity of the new fluoroquinolone trovafloxacin (CP-99,219) was compared with that of ciprofloxacin and ofloxacin against 517 bacterial isolates representing 50 different species. Against members of the family Enterobacteriaceae, all three drug
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:1633-1639
More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxaci